All
Xtandi and Talzenna Therapy Shows Responses in Advanced Prostate Cancer
Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in terms of prostate cancer therapy.
Tedopi Cancer Vaccine Meets Trial End Point For Pancreatic Cancer
The phase 2 TEDOPaM trial evaluating patients with advanced or metastatic pancreatic ductal adenocarcinoma met its primary end point.
Bringing Together the CAR T-Cell Therapy Community
It’s easy to think of scientific researchers as existing in a vacuum.
Nutrition is Key Following a Cancer Diagnosis
Nutrition is a challenge for many patients with cancer.
The Leukemia & Lymphoma Society is Helping Patients With Medial Debt
Cancer is one of the most expensive medical conditions to treat in the U.S.
Discussing the Mission of CURE With Our Former and New Editors-In-Chief
Our longtime editor-in-chief offers advice to his successor while discussing the news and education CURE magazine provides for patients with cancer, families and caregivers.
Four Things to Remember When Both Spouses Have Cancer
When my spouse and I both faced cancer, maintaining a positive attitude, seeking support, listening empathetically and managing stress helped us through it.
First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA.
Targeted Axillary Dissection Offers a Precise Option in Breast Cancer
Dr. Kandace P. McGuire discusses how targeted axillary staging differs from traditional methods of staging in patients undergoing breast cancer treatment.
RECKGIST Score May Predict Recurrence in Neurofibromatosis Type 1 GISTs
RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according to study findings.
Guiding Patients Through Shared Decision-Making in Breast Cancer Care
Kelly Grosklags discusses how oncologists can guide patients in shared decision-making while managing expectations following a breast cancer diagnosis.
Insights into the Latest Trends in Pancreatic Cancer
This month’s Research Spotlight highlights significant advancements in pancreatic cancer research and patient support.
First Patient Enrolled in Phase 3 Recurrent Prostate Cancer Trial
The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence following a prostatectomy.
Surviving Life-Threatening Lung Cancer: Lessons Learned
Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling.
Vepdegestrant May Reduce Disease Progression in Breast Cancer Subset
Vepdegestrant improved progression-free survival in patients with estrogen receptor 1 mutations in advanced ER-positive, HER2-negative breast cancer.
JAK Inhibitors Reduce Thromboembolic Risk in Myeloproliferative Neoplasm Therapy
JAK inhibitor treatment is associated with a reduction in risk of thromboembolic events for patients with myeloproliferative neoplasms.
Pimitespib Associated With Stable Disease for Some Patients With GIST
Treatment with pimitespib was associated with stable disease in two-thirds of patients with advanced gastrointestinal stromal tumors.
Expert Explains Early Signs, Treatment Advances and Care in Multiple Myeloma
Dr. Joseph Mikhael discusses early signs, treatments and supportive care for multiple myeloma in an interview with CURE.
Lenvima Plus Keytruda With TACE May Improve Liver Cancer Outcomes
For patients with unresectable, non-metastatic hepatocellular carcinoma, Lenvima plus Keytruda in combination with TACE improved outcomes.
On Alcohol Addiction for the Patient With Cancer
As a cancer survivor, I overcame alcohol addiction and urge others to seek support, safe detox and sobriety to improve their treatment and recovery.
Understanding the Best Practices Associated With CDK4/6 Therapy in Breast Cancer
Dr. Sara M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer.
We Have Come a Long Way
CURE magazine's outgoing editor-in-chief, Dr. Debu Tripathy, reflects on 18 years of advances in cancer care, the impact of AI and the evolving future of oncology treatment.
Gleevec Response in GIST May Be Linked to Mutational Profile
Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing mutation testing for treatment decisions.
ctDNA May Predict Biliary Tract Cancer Relapse, Recurrence
Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage biliary tract cancer.
FDA Approves Biosimilars for Cancer-Related Skeletal Events
The FDA has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer.
Imfinzi Plus Chemo May Improve Event-Free Survival in Gastric, GEJ Cancers
Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric and gastroesophageal junction cancers.
177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset
177Lu-edotreotide shows potential to extend progression-free survival in patients with grade 1 or 2 somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
The Dawn of a New Era in Cancer Treatment
New advancements in cancer treatment are reducing the need for radical surgeries, offering organ-sparing therapies and enhancing survivorship care and support for patients.
Challenging Cancer Stereotypes While Living with Follicular Lymphoma
Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied experiences of patients with cancer.
BRCA1/2 Mutations May Associate With Better Chemo Response in TNBC
Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in patients with BRCA1/2 mutations.
